A Study of Olaratumab (LY3012207) Doxorubicin and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Brief description of study

The purpose of this study is to evaluate the safety of ifosfamide when added to the combination regimen of olaratumab and doxorubicin in participants with advanced or metastatic soft tissue sarcoma (STS).

Clinical Study Identifier: NCT03283696

Start Over

Peter Reichardt

HELIOS Klinikum Berlin-Buch

Berlin, Germany

5.34miles

View all locations

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

A Study of Olaratumab (LY3012207) Doxorubicin and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Brief description of study

Enter your location

Peter Reichardt

Receive Emails About New Clinical Trials!